133 related articles for article (PubMed ID: 22759803)
1. Negative impact of linezolid on human neutrophil functions in vitro.
Grüger T; Schmidt T; Schnitzler N; Nidermajer S; Brandenburg K; Zündorf J
Chemotherapy; 2012; 58(3):206-11. PubMed ID: 22759803
[TBL] [Abstract][Full Text] [Related]
2. Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
Wareham DW; Abbas H; Karcher AM; Das SS
J Infect; 2006 Apr; 52(4):300-4. PubMed ID: 16099052
[TBL] [Abstract][Full Text] [Related]
3. Linezolid and human polymorphonuclear leukocyte function.
Naess A; Stenhaug Kilhus K; Nystad TW; Sørnes S
Chemotherapy; 2006; 52(3):122-4. PubMed ID: 16612054
[TBL] [Abstract][Full Text] [Related]
4. Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.
Wilcox MH; Tack KJ; Bouza E; Herr DL; Ruf BR; Ijzerman MM; Croos-Dabrera RV; Kunkel MJ; Knirsch C
Clin Infect Dis; 2009 Jan; 48(2):203-12. PubMed ID: 19072714
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility of staphylococci to linezolid and other antimicrobial agents.
Poiată A; Tuchiluş C; Bădicuţ I; Grigore L; Buiuc D
Roum Arch Microbiol Immunol; 2002; 61(4):293-9. PubMed ID: 15055263
[TBL] [Abstract][Full Text] [Related]
6. Effect of linezolid on the phagocytic functions of human polymorphonuclear leukocytes.
Ballesta S; Pascual A; García I; Perea EJ
Chemotherapy; 2003 Jul; 49(4):163-6. PubMed ID: 12886050
[TBL] [Abstract][Full Text] [Related]
7. Linezolid resistance in coagulase-negative staphylococci.
Kelly S; Collins J; Davin M; Gowing C; Murphy PG
J Antimicrob Chemother; 2006 Oct; 58(4):898-9; author reply 899-900. PubMed ID: 16854956
[No Abstract] [Full Text] [Related]
8. Experience with linezolid therapy in children with osteoarticular infections.
Chen CJ; Chiu CH; Lin TY; Lee ZL; Yang WE; Huang YC
Pediatr Infect Dis J; 2007 Nov; 26(11):985-8. PubMed ID: 17984803
[TBL] [Abstract][Full Text] [Related]
9. [Resistance to linezolid in Staphylococcus aureus before its release].
Akpabie A; Naga H; Giraud K; Al Rahiss R; Nadai S
Pathol Biol (Paris); 2004 Oct; 52(8):493-6. PubMed ID: 15465271
[TBL] [Abstract][Full Text] [Related]
10. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates.
Deville JG; Adler S; Azimi PH; Jantausch BA; Morfin MR; Beltran S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S158-63. PubMed ID: 14520141
[TBL] [Abstract][Full Text] [Related]
11. Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA.
Meka VG; Pillai SK; Sakoulas G; Wennersten C; Venkataraman L; DeGirolami PC; Eliopoulos GM; Moellering RC; Gold HS
J Infect Dis; 2004 Jul; 190(2):311-7. PubMed ID: 15216466
[TBL] [Abstract][Full Text] [Related]
12. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections.
Chien JW; Kucia ML; Salata RA
Clin Infect Dis; 2000 Jan; 30(1):146-51. PubMed ID: 10619743
[TBL] [Abstract][Full Text] [Related]
13. [In vitro susceptibility to linezolid in methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus strains].
Efe S; Sinirtaş M; Ozakin C
Mikrobiyol Bul; 2009 Oct; 43(4):639-43. PubMed ID: 20084917
[TBL] [Abstract][Full Text] [Related]
14. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M
Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
[TBL] [Abstract][Full Text] [Related]
15. [The first clinical experiences in Hungary with a new effective antibiotic (linezolid) effective against Gram-positive infections].
Pulay I; Konkoly TM; Zsirka KA; Csapó Z; Flautner L; Tihanyi T
Orv Hetil; 2003 Jan; 144(1):29-33. PubMed ID: 12635350
[TBL] [Abstract][Full Text] [Related]
16. In vivo efficacy of linezolid in combination with gentamicin for the treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Jacqueline C; Asseray N; Batard E; Le Mabecque V; Kergueris MF; Dube L; Bugnon D; Potel G; Caillon J
Int J Antimicrob Agents; 2004 Oct; 24(4):393-6. PubMed ID: 15380267
[TBL] [Abstract][Full Text] [Related]
17. Enhanced activity of linezolid against Staphylococcus aureus in cerebrospinal fluid.
Schwameis R; Fille M; Manafi M; Zeitlinger M; Sauermann R
Res Microbiol; 2012 Apr; 163(3):157-60. PubMed ID: 22210435
[TBL] [Abstract][Full Text] [Related]
18. [Linezolid--novel antibiotic for the treatment of gram-positive bacterial infections].
Jankowski A; Stefanik W
Wiad Lek; 2006; 59(9-10):727-31. PubMed ID: 17338140
[TBL] [Abstract][Full Text] [Related]
19. Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens.
Jantausch BA; Deville J; Adler S; Morfin MR; Lopez P; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S164-71. PubMed ID: 14520142
[TBL] [Abstract][Full Text] [Related]
20. Linezolid in the treatment of Gram-positive prosthetic joint infections.
Bassetti M; Vitale F; Melica G; Righi E; Di Biagio A; Molfetta L; Pipino F; Cruciani M; Bassetti D
J Antimicrob Chemother; 2005 Mar; 55(3):387-90. PubMed ID: 15705640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
